Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
作者信息
Materson B J
机构信息
Department of Medicine, University of Miami, Florida 33136, USA.
出版信息
Am J Hypertens. 1999 Jan;12(1 Pt 2):1S-2S.
PMID:10077412
Abstract
摘要
相似文献
1
Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.降低高血压相关的心肾风险：心率、左心室肥厚逆转及肾脏保护的作用
Am J Hypertens. 1999 Jan;12(1 Pt 2):1S-2S.
2
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.高血压患者心房颤动发生率与心率随时间变化的关系：LIFE研究
Circ Arrhythm Electrophysiol. 2008 Dec;1(5):337-43. doi: 10.1161/CIRCEP.108.795351. Epub 2008 Dec 2.
3
[Impact of antihypertensive treatment on target organs].[抗高血压治疗对靶器官的影响]
Arch Cardiol Mex. 2002 Jan-Mar;72 Suppl 1:S58-63.
4
Slower heart rates for healthy hearts: time to redefine tachycardia?健康心脏的心率较慢：是时候重新定义心动过速了吗？
Circ Arrhythm Electrophysiol. 2008 Dec;1(5):321-3. doi: 10.1161/CIRCEP.108.835264.
5
[The primary and secondary prevention of hypertensive cardiopathy].高血压性心脏病的一级和二级预防
Ital Heart J. 2000 Jun;1 Suppl 2:59-66.
6
Hypertensive heart disease.高血压性心脏病
Hypertens Res. 2005 Mar;28(3):191-202. doi: 10.1291/hypres.28.191.
7
The effect of alpha-blockers on cardiac function.
J Assoc Physicians India. 1998;Suppl 1:11-4.
8
Left ventricular hypertrophy in hypertension.
N Engl J Med. 1999 Apr 22;340(16):1279-80. doi: 10.1056/NEJM199904223401610.
9
[Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].[抗高血压治疗：糖尿病和心脏疾病中的风险分层]
MMW Fortschr Med. 2006 Mar 16;148(11):57, 59-60.
10
Hypertension and the heart.高血压与心脏
Semin Cardiothorac Vasc Anesth. 2006 Sep;10(3):198-202. doi: 10.1177/1089253206291315.
Zotero 插件